Bibliografia

[1] Noonan, C. W. (2017). Environmental asbestos exposure and risk of mesothelioma. Annals of Translational Medicine.

[2] Sistema Nacional de Saúde, Instituto Doutor Ricardo Jorge - Amianto (Consultado em 28.04.2017)

[3] Moutinho, Christian. (2016). Reabilitação de edifícios onde existe amianto. (Tese de mestrado, Universidade de Trás-os-Montes e Alto Douro)

[4] Janela, J., & Pereira, P. (2016). História do amianto no mundo e em Portugal. CEM/Cultura, Espaço e Memória. Dossier temático «Cruzar fronteiras: ligar as margens da história ambiental/Crossing Borders: connecting edges of environmental history», 7, 193-206.

[5] Direção Geral de Saúde - Amianto (Consultado em 28.04.2017)

[6] https://www.epa.gov/asbestos/protect-your-family (Consultado em 28.04.2017)

[7] http://www.ipac.pt/pesquisa/ficha_lae.asp?id=L0323 (Consultado em 28.04.2017)

[8] IARC Monographs on the evaluation of the carcinogenic risk of chemicals to Man: asbestos, 14 (1977).

[9] Manning, Christopher B., Val Vallyathan, and Brooke T. Mossman. "Diseases caused by asbestos: mechanisms of injury and disease development." International immunopharmacology 2.2 (2002): 191-200.

[10] Wolff, Henrik, et al. "Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations." Scandinavian journal of work, environment & health 41.1 (2015): 5-15.

[11] Landrigan, Philip J., and Richard A. Lemen PhD10. "Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update." (2017).

[12] Roggli, Victor, et al. "Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a Critique." Archives of pathology & laboratory medicine 140.9 (2016): 950-952.

[13] http://www.nhs.uk/conditions/Asbestosis/Pages/Introduction.aspx (Consultado em 27.04.2017)

[14] Norbet, Christopher, et al. "Asbestos-related lung disease: a pictorial review." Current problems in diagnostic radiology 44.4 (2015): 371-382.

[15] Patel, Shivani C., and Jonathan E. Dowell. "Modern management of malignant pleural mesothelioma." Lung Cancer: Targets and Therapy 7 (2016): 63.

[16] Nabavi, Noushin, et al. "Switching off malignant mesothelioma: exploiting the hypoxic microenvironment." Genes & cancer 7.11-12 (2016): 340.

[17] Bibby, Anna C., et al. "Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment." European Respiratory Review 25.142 (2016): 472-486.

[18] Nielsen, Lene Snabe, et al. "Occupational asbestos exposure and lung cancer—a systematic review of the literature." Archives of environmental & occupational health 69.4 (2014): 191-206.

[19] http://www.elcosh.org/document/49/25/d000486/section2.html (Consultado em 15.05.2017)

[20] Markowitz, Steven B., et al. "Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort." American journal of respiratory and critical care medicine 188.1 (2013): 90-96.

[21] https://www.asbestos.com/cancer/lung-cancer/ (Consultado em 15.05.2017)

[22] Fujimoto, Nobukazu, et al. "Clinical investigation of benign asbestos pleural effusion." Pulmonary medicine 2015 (2015).

[23] Meirelles, G. S. P., et al. "Placas pleurais relacionadas com o asbesto: Revisão da Literatura." Revista Portuguesa de Pneumologia 11.5 (2005): 487-497.

[24] https://www.asbestos.com/mesothelioma/pleural-thickening.php (Consultado em 17.05.2017)

[25] https://www.asbestos.com/mesothelioma/pleural-effusion.php (Consultado em 17.05.2017)

[26] Robinson, B. W., and A. W. Musk. "Benign asbestos pleural effusion: diagnosis and course." Thorax 36.12 (1981): 896-900.

[27] Donaldson, Ken, et al. "Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma." Particle and fibre toxicology 7.1 (2010): 5.

[28] Liu, G., P. Cheresh, and D.W. Kamp, Molecular basis of asbestos-induced lung disease. Annu Rev Pathol, 2013. 8: p. 161-87.

[29] Benedetti, S., et al., Reactive oxygen species a double-edged sword for mesothelioma. Oncotarget, 2015. 6(19): p. 16848-65

[30] https://www.bio-rad-antibodies.com/mitochondria-molecule-antibodies.html (Consultado em 16.5.2017)

[31] http://www.naturesalternativepdx.com/blog/cannabis-and-cancer/page/2/ (Consultado em 16.5.2017)

[32] Kim, S.-J., et al., The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis. International Journal of Molecular Sciences, 2015. 16(9).

[33] Decreto-Lei 266/2007 de 24 de Julho do Ministério do Trabalho e da Solidariedade Social . Diário da República: 1.ª série, N.º 141 (2007)